MedPath

JLP-2002

Generic Name
JLP-2002

The Safety and PK Characteristics of the Co-administration of JLP-2002 and Comparator in Healthy Volunteers

Phase 1
Completed
Conditions
Overactive Bladder(OAB)
Interventions
Drug: Comparator
First Posted Date
2021-06-04
Last Posted Date
2021-06-14
Lead Sponsor
Jeil Pharmaceutical Co., Ltd.
Target Recruit Count
42
Registration Number
NCT04914221
Locations
🇰🇷

Samsung Medical Center, Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath